Thrivent Financial for Lutherans
IMCR icon

Thrivent Financial for Lutherans’s Immunocore IMCR Stock Holding History

Thrivent Financial for Lutherans’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-205,243
Closed -$6.96M – 2553
2024
Q2 		$6.96M Sell
205,243
-8,747
-4% -$446K 0.01% 778
2024
Q1 		$13.9M Buy
213,990
+2,159
+1% +$148K 0.03% 559
2023
Q4 		$14.5M Sell
211,831
-4,094
-2% -$213K 0.03% 520
2023
Q3 		$11.2M Buy
215,925
+2,842
+1% +$168K 0.03% 574
2023
Q2 		$12.8M Sell
213,083
-3,974
-2% -$227K 0.03% 564
2023
Q1 		$10.7M Buy
217,057
+3,289
+2% +$185K 0.03% 596
2022
Q4 		$12.2M Buy
213,768
+3,897
+2% +$219K 0.03% 546
2022
Q3 		$9.85M Sell
209,871
-159,633
-43% -$7.61M 0.03% 593
2022
Q2 		$13.8M Sell
369,504
-18,190
-5% -$591K 0.04% 503
2022
Q1 		$11.6M Buy
387,694
+32,611
+9% +$823K 0.02% 636
2021
Q4 		$12.2M Buy
355,083
+4,869
+1% +$176K 0.02% 620
2021
Q3 		$13M Buy
350,214
+1,400
+0.4% +$47.3K 0.03% 598
2021
Q2 		$13.6M Buy
348,814
+28,562
+9% +$1.1M 0.03% 592
2021
Q1 		$13.6M Buy
+320,252
New +$14.3M 0.03% 574

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Thrivent Financial for Lutherans's IMCR Position: Q3 2024 in Review

Thrivent Financial for Lutherans sold out of Immunocore (IMCR) in Q3 2024, closing a stake of 205,243 shares — an estimated $6.96M sold.

Thrivent Financial for Lutherans first reported a position in IMCR in Q1 2021 and held it in 14 quarters. The position peaked at $14.5M in Q4 2023. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2024.

  • Thrivent Financial for Lutherans reported no remaining Immunocore position as of Q3 2024 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 205,243 Immunocore shares in Q3 2024, an estimated $6.96M.
  • Thrivent Financial for Lutherans first reported a position in Immunocore in Q1 2021 and held it in 14 quarters.
  • Thrivent Financial for Lutherans's Immunocore position peaked at $14.5M in Q4 2023.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2024.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2024, filed 7 Nov 2024.